Robust risk committee is need of the hour: Dr Mazumdar-Shaw
India | Regulatory | By BioSpectrum Bureau | 1 Comment | 28 Aug, 2012
Bangalore: Risk management should be seen as an opportunity and innovative approaches are required to address mission cr...Read more
Antibody R&D: What APAC firms are working on?
India | Analysis | By BioSpectrum Bureau | 0 Comment | 03 Oct, 2012
Over the years, some of the Asian companies have made significant breakthroughs in antibody research and are exploring f...Read more
More pharma FDI proposals cleared by India
India | News | By BioSpectrum Bureau | 0 Comment | 04 Sep, 2013
Singapore: Providing a final nod to 17 Foreign Direct Investment (FDI) proposals in India across various sectors, the co...Read more
Dr Saleem Mohammad, Xcode Lifesciences: DNA-based customized medical care on anvil
India | Opinion | By BioSpectrum Bureau | 0 Comment | 26 Dec, 2012
If you are unwell, you could visit a doctor, but no longer will you be taking general medication for a range of possible...Read more
Sun Pharma settles Gleevec compound litigation
India | Regulatory | By BioSpectrum Bureau | 3 Comment | 20 May, 2014
Singapore: Novartis Pharmaceuticals has reported to settle its litigation with US subsidiary of India based Sun Pharmace...Read more
Piramal Alzheimer's detector gets FDA, EMA nod
India | News | By BioSpectrum Bureau | 0 Comment | 22 Mar, 2013
Singapore: The US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted Piramal Imagi...Read more
Pharmacovigilance: A strategic opportunity
India | Opinion | By BioSpectrum Bureau | 2 Comment | 06 Sep, 2012
For many Asian pharmaceutical companies, pharmacovigilance is a critical component of any drug development program. As p...Read more
Pfenex, Agila JV to develop biosimilar
India | News | By BioSpectrum Bureau | 0 Comment | 17 Apr, 2013
Bangalore: US-based Pfenex and India-based Agila Biotech, a subsidiary of Strides Arcolab, entered into a joint venture ...Read more
Lack of collective voice hampers biosupplier sector
India | Influencers | By BioSpectrum Bureau | 1 Comment | 28 Feb, 2013
Started in 1999, India-based GenAxy Scientific with its corporate office in New Delhi and head office in Solan, has made...Read more
MNCs boost Asia biologics industry
India | News | By BioSpectrum Bureau | 0 Comment | 07 Mar, 2012
Entry of multinational companies has been a big boost to Asia's position in biologics manufacturing, especially with cGM...Read more
Lupin gets FDA approval for Lyrica generic
India | Regulatory | By BioSpectrum Bureau | 3 Comment | 06 Jul, 2012
Mumbai: Pharma major Lupin's subsidiary, Lupin Pharmaceuticals, has received final approval for its pregabalin capsules,...Read more
Bioagri inching towards saturation in India
India | Analysis | By BioSpectrum Bureau | 0 Comment | 06 Aug, 2012
The BioAgri sector has registered a record revenue of $621 million as compared to previous year's revenue of $140 millio...Read more
LifeCell diversifies from cell banking to diagnostics, vaccine
India | Influencers | By BioSpectrum Bureau | 3 Comment | 31 Dec, 2012
LifeCell International, India's largest private stem cell bank and the first stem cell solution provider to bring the co...Read more
Venus bags first patent from Canada for Vancoplus
India | Regulatory | By BioSpectrum Bureau | 1 Comment | 12 Sep, 2012
New Delhi: Chandigarh-based Venus Remedies, a leading research based global pharmaceutical company secured its first pat...Read more
Indian state to slash prices of 348 drugs
India | News | By BioSpectrum Bureau | 0 Comment | 23 Jul, 2013
Singapore: Tripura has become the first Indian state to announce its implementation of the country's health ministry's d...Read more
GVK licenses its biomarker database to National Cancer Institute
India | News | By BioSpectrum Bureau | 0 Comment | 07 Sep, 2012
Singapore: GVK Biosciences, Asia's leading contract research organization (CRO) has licensed its popular clinical bioma...Read more
FDA to India: Regulatory compliance a must
India | News | By BioSpectrum Bureau | 0 Comment | 14 May, 2014
Singapore: "Make quality the top priority," was the clear message from the FDA officials to Indian Pharma companies. A ...Read more
Projects under Indo-Australia Biotechnology Fund
India | Analysis | By BioSpectrum Bureau | 0 Comment | 18 May, 2012
...Read more